Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease

Annals of Neurology

Volumn 46, Issue 3, 1999, Pages 412-416

  Mayeux, Richard ^a,b,c   Tang, Ming Xin ^a,b,c   Jacobs, Diane M ^a,b,c   Manly, Jennifer ^a,b,c   Bell, Karen ^a,b,c   Merchant, Carol ^a,b,c   Small, Scott A ^a,b,c   Stern, Yaakov ^a,b,c   Wisniewski, Henry M ^d   Mehta, Pankaj D ^b  

^a Alzheimer's Disease Research Center   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0032869023     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A     Document Type: Article

References (17)

1. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994;13:45-53
2. Iwatsubo T, Mann DM, Odaka A, et al. Amyloid beta protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995;37:294-299
3. Borchelt DR, Thinakaran G, Eckman CB, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevated Aβ 1-42/ 1-40 ration in vitro and in vivo. Neuron 1996;17:1005-1013
4. Duff K, Eckman C, Zehr C, et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 1996; 383:710-713
5. Citron M, Westaway D, Xia W, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat Med 1997;3:67-72
6. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-869
7. Kosaka T, Imagawa M, Seki K, et al. The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid beta protein ending at A beta42(43). Neurology 1997;48:741-745
8. Stern Y, Andrews H, Pittman J, et al. Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 1992;49: 453-460
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-944
10. Hughes CP, Berg L, Danziger W, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572
11. Mehta PD, Dalton AJ, Mehta SP, et al. Increased plasma amyloid β protein 1-42 levels in Down syndrome. Neurosci Lett 1998;241:13-16
12. Potempska A, Mack K, Mehta PD, et al. Quantification of subfemtomole amounts of Alzheimer amyloid β peptides. Amyloid 1999;6:14-21
13. Jensen M, Schröder J, Blomberg M, et al. Cerebrospinal fluid Aβ42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol 1999;45:504-511
14. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 1997;17:263-264
15. Xia W, Zhang J, Kholodenko D, et al. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem 1997;272:7977-7982
16. Younkin SG, Younkin LH, Kawarabayashi T, et al. Role of increased amyloid β protein (Aβ) in Alzheimer's disease. Neurobiol Aging 1998;19(4S):S2 (Abstract)
17. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 1995;38:643-648